Unravelling the role of NFE2L1 in stress responses and related diseases

• Published in: Redox biology Vol. 65; p. 102819
• Main Authors: Liu, Xingzhu, Xu, Chang, Xiao, Wanglong, Yan, Nianlong
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.09.2023; Elsevier
• Subjects: Adaptive responses; Cancer; Neurodegeneration; NFE2L1; Oxidative stress; Proteasome; Review; Oxidative stress; Adaptive responses; Neurodegeneration; NFE2L1; Proteasome; Cancer
• ISSN: 2213-2317; 2213-2317
• DOI: 10.1016/j.redox.2023.102819

The nuclear factor erythroid 2 (NF-E2)-related factor 1 (NFE2L1, also known as Nrf1) is a highly conserved transcription factor that belongs to the CNC-bZIP subfamily. Its significance lies in its control over redox balance, proteasome activity, and organ integrity. Stress responses encompass a series of compensatory adaptations utilized by cells and organisms to cope with extracellular or intracellular stress initiated by stressful stimuli. Recently, extensive evidence has demonstrated that NFE2L1 plays a crucial role in cellular stress adaptation by 1) responding to oxidative stress through the induction of antioxidative responses, and 2) addressing proteotoxic stress or endoplasmic reticulum (ER) stress by regulating the ubiquitin-proteasome system (UPS), unfolded protein response (UPR), and ER-associated degradation (ERAD). It is worth noting that NFE2L1 serves as a core factor in proteotoxic stress adaptation, which has been extensively studied in cancer and neurodegeneration associated with enhanced proteasomal stress. In these contexts, utilization of NFE2L1 inhibitors to attenuate proteasome "bounce-back" response holds tremendous potential for enhancing the efficacy of proteasome inhibitors. Additionally, abnormal stress adaptations of NFE2L1 and disturbances in redox and protein homeostasis contribute to the pathophysiological complications of cardiovascular diseases, inflammatory diseases, and autoimmune diseases. Therefore, a comprehensive exploration of the molecular basis of NFE2L1 and NFE2L1-mediated diseases related to stress responses would not only facilitate the identification of novel diagnostic and prognostic indicators but also enable the identification of specific therapeutic targets for NFE2L1-related diseases. [Display omitted] •NFE2L1 maintains redox balance via modulating antioxidant genes and mitochondrial homeostasis.•NFE2L1 participates in adaptive defense against proteotoxic stress via proteosome synthesis and ERAD promotion.•NFE2L1 may partially constitute a novel ramification of UPRER and UPRmt.•NFE2L1 involves in the anticancer therapy via regulating ubiquitin-proteasome-system (UPS).